Quantis Biotech India Private Limited
About Quantis Biotech India Private Limited
Data last updated:
Quantis Biotech India Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2017PTC059390. Its GSTIN is 08AAACQ5021G1ZR (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deen Dayal Sharma and Rituraj Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 63 Devi Nagar Harnathpura Ward No 11 Kalwar Road, Jaipur, Rajasthan, India – 302012.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.18 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹51,599 (net margin 0.4%) and EBITDA of ₹90,719 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 114% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Quantis Biotech India Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address63 Devi Nagar Harnathpura Ward No 11 Kalwar Road, Jaipur, Rajasthan, India – 302012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Quantis Biotech India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Quantis Biotech India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Quantis Biotech India Private Limited, buy the company report.
Financials of Quantis Biotech India Private Limited
FY 2023 filings availableQuantis Biotech India Private Limited reported revenue of ₹1.18 Cr (up 156% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 114% over five years, including 156% growth in the latest year. EBITDA rose 994% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90,719 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51,599 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Quantis Biotech India Private Limited, buy the company report.
Board of directors of Quantis Biotech India Private Limited
Quantis Biotech India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deen Dayal Sharma | Director | 30 Oct 2017 | 9 Years 0 Months | Current |
| Rituraj Bhardwaj Also directs: Shining Universal Organisation Private Limited | Director | 30 Oct 2017 | 9 Years 0 Months | Current |
Peer comparison
Quantis Biotech India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alvista Labs Private Limited | ₹1.18 Cr (FY 2025) | 48.0% | Agra, Uttar Pradesh, India | |||
| Nexure Lifesciences Private Limited | ₹1.18 Cr (FY 2025) | -16.0% | Agra, Uttar Pradesh, India | |||
| Elite Multiventures Private Limited | ₹1.18 Cr (FY 2021) | -46.0% | Nagpur, Maharashtra, India | |||
| Vividha Pharmaceutical and Surgical Distributors Private Limited | ₹1.18 Cr (FY 2022) | -33.0% | Dharwad, Karnataka, India | |||
| Quantis Biotech India Private Limitedthis company | ₹1.18 Cr (FY 2023) | ₹51,599 | 0.4% | 156.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Quantis Biotech India Private Limited, buy the company report.
Auditor
Quantis Biotech India Private Limited is audited by ANKIT K JAIN AND ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT K JAIN AND ASSOCIATES | FY 2021 | 021059C |
Shareholding
The shareholding of Quantis Biotech India Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Quantis Biotech India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Mar 2019 | 100248279 | Vijaya Bank | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Quantis Biotech India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quantis Biotech India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Quantis Biotech India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACQ5021G1ZR | Rajasthan | Active | 05 Jan 2018 |
To see the full GST registrations and return filing status of Quantis Biotech India Private Limited, buy the company report.
Recent activity
Quantis Biotech India Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Deen Dayal Sharma was appointed as Director on 30 Oct 2017.
Frequently asked questions
Quantis Biotech India is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 October 2017 (9+ years old) and is registered under CIN U74999RJ2017PTC059390.
Quantis Biotech India has 2 current directors:
- Deen Dayal Sharma - Director
- Rituraj Bhardwaj - Director
The latest financial statements of Quantis Biotech India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Quantis Biotech India is 08AAACQ5021G1ZR, registered in Rajasthan.
The CIN (Corporate Identification Number) of Quantis Biotech India is U74999RJ2017PTC059390. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quantis Biotech India was incorporated on 30 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Quantis Biotech India by revenue are Alvista Labs Private Limited, Nexure Lifesciences Private Limited, Elite Multiventures Private Limited, Vividha Pharmaceutical and Surgical Distributors Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Deen Dayal Sharma was appointed as Director on 30 Oct 2017. Rituraj Bhardwaj was appointed as Director on 30 Oct 2017.
The registered office of Quantis Biotech India is at 63 Devi Nagar Harnathpura Ward No 11 Kalwar Road, Jaipur, Rajasthan, India – 302012.
Quantis Biotech India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Quantis Biotech India has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
